{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:47:14Z","timestamp":1793292434155,"version":"4.5.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiovascular disease that affects individuals worldwide. While current treatments have improved the prognosis for many patients, HCM continues to impose a significant burden on global healthcare systems. Understanding its underlying mechanisms, particularly the role of metabolic transition, is crucial for enhancing diagnosis and treatment strategies. One of the most promising areas of research in HCM is the study of metabolic transition. This process, which involves significant changes in energy production and consumption within cardiac cells, has become increasingly recognized as a key factor in the disease\u2019s progression. In HCM, glucose metabolism is markedly altered. The heart increasingly relies on glycolysis for energy production, while the aerobic oxidation of glucose is impaired. These changes are accompanied by alterations in the activity of glucose transporter proteins and key enzymes involved in glycolysis. Such abnormalities are closely associated with myocardial ischemia, fibrosis, and an increased risk of acidosis in cardiomyocytes, which in turn affects calcium cycling and cardiac diastolic function. Lipid metabolism is significantly altered in HCM. There is a defect in fatty acid \u03b2-oxidation, leading to the accumulation of ceramides and sphingomyelins in cardiomyocytes. Additionally, changes in ketone body metabolism occur as an adaptive response to energy deficiency, which may further affect cardiac function. Amino acid metabolism is also altered in HCM. Elevated levels of branched-chain amino acids have been observed, and these metabolites are strongly associated with cardiac remodeling and the development of insulin resistance. These changes further contribute to the maladaptive processes in HCM. A comprehensive understanding of the metabolic transition process in HCM is essential for unraveling the disease\u2019s pathogenesis. Such insights could pave the way for novel therapeutic strategies, ultimately improving patient outcomes and quality of life.<\/jats:p>","DOI":"10.3389\/fphys.2025.1700313","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:20:03Z","timestamp":1762924803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms of metabolic transition in hypertrophic cardiomyopathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Conghao","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0188479","DOI":"10.1371\/journal.pone.0188479","article-title":"Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography","volume":"12","author":"Aoyama","year":"2017","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.rec.2020.08.030","article-title":"Metabolic \u201cace of spades\u201d in apical hypertrophic cardiomyopathy","volume":"74","author":"Barrio","year":"2021","journal-title":"Rev. Espa\u00f1ola Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00059-020-04899-y","article-title":"Hypertrophe kardiomyopathie","volume":"45","author":"Batzner","year":"2020","journal-title":"Herz"},{"key":"B6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10741-024-10440-8","article-title":"Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM","volume":"30","author":"Beghini","year":"2024","journal-title":"Heart Fail Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial dysfunction and oxidative stress in metabolic disorders \u2014 a step towards mitochondria based therapeutic strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjcard.2023.10.075","article-title":"Hypertrophic cardiomyopathy: a brief overview","volume":"212","author":"Braunwald","year":"2024","journal-title":"Am. J. Cardiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/01.cir.29.3.422","article-title":"Idiopathic hypertrophic subaortic stenosis: I. A description of the disease based upon an analysis of 64 patients","volume":"29","author":"Braunwald","year":"1964","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e007537","DOI":"10.1161\/CIRCHEARTFAILURE.120.007537","article-title":"Clinical profile and health disparities in a multiethnic cohort of patients with hypertrophic cardiomyopathy","volume":"14","author":"Butters","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.amjcard.2021.08.024","article-title":"Clinical diagnosis of hypertrophic cardiomyopathy over time in the United States (A population-based claims analysis)","volume":"159","author":"Butzner","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.123.065880","article-title":"Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?","volume":"149","author":"Chen","year":"2024","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"H1237","DOI":"10.1152\/ajpheart.00727.2014","article-title":"Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy","volume":"308","author":"Christiansen","year":"2015","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/antiox13020209","article-title":"Role of perilipins in oxidative stress\u2014implications for cardiovascular disease","volume":"13","author":"Cinato","year":"2024","journal-title":"Antioxidants"},{"key":"B16","doi-asserted-by":"publisher","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","article-title":"Ketone body metabolism and cardiovascular disease","volume":"304","author":"Cotter","year":"2013","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40364-025-00768-0","article-title":"Comprehensive plasma metabolomics profiling develops diagnostic biomarkers of obstructive hypertrophic cardiomyopathy","volume":"13","author":"Cui","year":"2025","journal-title":"Biomark. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1139\/y11-019","article-title":"Thirty years of research on atrial natriuretic factor: historical background and emerging concepts","volume":"89","author":"De Bold","year":"2011","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaccao.2023.12.006","article-title":"Cardiac troponin in patients with light Chain andcTransthyretin Cartiac Amyloidosis: JACC: cardioancology State-of-the-Art Review","volume":"6","author":"De Michieli","year":"2024","journal-title":"CardioOncology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/metabo11110787","article-title":"The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy","volume":"11","author":"Deidda","year":"2021","journal-title":"Metabolites"},{"key":"B21","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circulation Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.hrthm.2022.10.018","article-title":"Prognostic significance of remotely monitored nocturnal heart rate in heart failure patients with reduced ejection fraction","volume":"20","author":"D\u2019Onofrio","year":"2023","journal-title":"Heart rhythm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1161\/CIRCULATIONAHA.118.035932","article-title":"Hypertrophic Cardiomyopathy: Lifelong Disease Requiring Lifelong Treatment","volume":"138","author":"Elliott","year":"2018","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.hrthm.2019.07.019","article-title":"The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy","volume":"17","author":"Finocchiaro","year":"2020","journal-title":"Heart rhythm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10654-017-0333-0","article-title":"Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts","volume":"33","author":"Floegel","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","article-title":"Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease","volume":"118","author":"Fuster","year":"2016","journal-title":"Circulation Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1093\/eurheartj\/ehx527","article-title":"Women with hypertrophic cardiomyopathy have worse survival","volume":"38","author":"Geske","year":"2017","journal-title":"Eur. Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2302\/kjm.2019-0012-OA","article-title":"Hypertrophic Cardiomyopathy: Diverse Pathophysiology Revealed by Genetic Research, Toward Future Therapy","volume":"69","author":"Hayashi","year":"2020","journal-title":"Keio J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1213\/ANE.0000000000000538","article-title":"Hypertrophic Cardiomyopathy: A Review","volume":"120","author":"Hensley","year":"2015","journal-title":"Anesth. and Analgesia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"894635","DOI":"10.3389\/fcell.2022.894635","article-title":"Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy","volume":"10","author":"Hsieh","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/CIRCGENETICS.115.001093","article-title":"Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection","volume":"8","author":"Ingles","year":"2015","journal-title":"Circ. Cardiovasc Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/13696998.2021.1978242","article-title":"Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States","volume":"24","author":"Jain","year":"2021","journal-title":"J. Med. Econ."},{"key":"B34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","article-title":"A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance","volume":"22","author":"Jang","year":"2016","journal-title":"Nat. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/ijms24044031","article-title":"Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants","volume":"24","author":"Jansen","year":"2023","journal-title":"IJMS"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0134184","DOI":"10.1371\/journal.pone.0134184","article-title":"The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy","volume":"10","author":"J\u00f8rgenrud","year":"2015","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1139\/cjpp-2024-0077","article-title":"Lysophosphatidic acid metabolism and signaling in heart disease","volume":"102","author":"Jose","year":"2024","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","article-title":"Is AMPK the savior of the failing heart?","volume":"26","author":"Kim","year":"2015","journal-title":"Trends Endocrinol. and Metabolism"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy Metabolic Reprogramming in the Hypertrophied and Early Stage Failing Heart: A Multisystems Approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"B40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pcad.2023.07.005","article-title":"Cardiovascular statistics 2023","volume":"79","author":"Lavie","year":"2023","journal-title":"Prog. Cardiovasc. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ Redox Balance as a Therapy for Heart Failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12967-017-1306-5","article-title":"The pathophysiological role of mitochondrial oxidative stress in lung diseases","volume":"15","author":"Liu","year":"2017","journal-title":"J. Transl. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3390\/jcm9061799","article-title":"Mitochondrial Energetics and Ca2+-Activated ATPase in Obstructive Hypertrophic Cardiomyopathy","volume":"9","author":"Lombardi","year":"2020","journal-title":"JCM"},{"key":"B44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cjca.2016.12.013","article-title":"Metabolic Modulators in Heart Disease: Past, Present, and Future","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can. J. Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/FJC.0b013e3181e74a14","article-title":"Energy Metabolic Phenotype of the Cardiomyocyte During Development, Differentiation, and Postnatal Maturation","volume":"56","author":"Lopaschuk","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e006657","DOI":"10.1161\/JAHA.117.006657","article-title":"Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy","volume":"7","author":"Lu","year":"2018","journal-title":"JAHA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circulation Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the CARDIA Study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijcard.2023.04.005","article-title":"How common is hypertrophic cardiomyopathy really? Disease prevalence revisited 27 years after CARDIA","volume":"382","author":"Massera","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.3390\/ijms25115855","article-title":"Genetic Mutations and Mitochondrial Redox Signaling as Modulating Factors in Hypertrophic Cardiomyopathy: A Scoping Review","volume":"25","author":"Menezes Junior","year":"2024","journal-title":"IJMS"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/jcp.25639","article-title":"The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy\u2010Progress and Novel Therapeutic Opportunities","volume":"232","author":"Mohamed","year":"2017","journal-title":"J. Cell. Physiology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.15252\/emmm.201404749","article-title":"Heart over mind: metabolic control of white adipose tissue and liver","volume":"6","author":"Nakamura","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The Failing Heart \u2014 An Engine Out of Fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1042\/CS20160036","article-title":"Protein kinase C mechanisms that contribute to cardiac remodelling","volume":"130","author":"Newton","year":"2016","journal-title":"Clin. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJM199804303381802","article-title":"Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy","volume":"338","author":"Niimura","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","article-title":"Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration","volume":"44","author":"Nollet","year":"2023","journal-title":"Eur. Heart J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e004369","DOI":"10.1161\/CIRCGEN.123.004369","article-title":"Integrating Clinical Phenotype With Multiomics Analyses of Human Cardiac Tissue Unveils Divergent Metabolic Remodeling in Genotype-Positive and Genotype-Negative Patients With Hypertrophic Cardiomyopathy","volume":"17","author":"Nollet","year":"2024","journal-title":"Circ Genomic Precis. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/S0140-6736(21)01205-8","article-title":"Hypertrophic cardiomyopathy: a practical approach to guideline directed management","volume":"398","author":"Ommen","year":"2021","journal-title":"Lancet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"B62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e000301","DOI":"10.1161\/JAHA.113.000301","article-title":"Inducible Overexpression of GLUT1 Prevents Mitochondrial Dysfunction and Attenuates Structural Remodeling in Pressure Overload but Does Not Prevent Left Ventricular Dysfunction","volume":"2","author":"Pereira","year":"2013","journal-title":"JAHA"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e009521","DOI":"10.1161\/CIRCHEARTFAILURE.121.009521","article-title":"Defects in the Proteome and Metabolome in Human Hypertrophic Cardiomyopathy","volume":"15","author":"Previs","year":"2022","journal-title":"Circ. Heart Fail."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy","volume":"144","author":"Ranjbarvaziri","year":"2021","journal-title":"Circulation"},{"key":"B67","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1023\/A:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects: A series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J Inher Metab Disea"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e007022","DOI":"10.1161\/CIRCHEARTFAILURE.120.007022","article-title":"Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy","volume":"14","author":"Schuldt","year":"2021","journal-title":"Circ. Heart Fail."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e004796","DOI":"10.1161\/JAHA.113.004796","article-title":"Glucose Regulation of Load\u2010Induced mTOR Signaling and ER Stress in Mammalian Heart","volume":"2","author":"Sen","year":"2013","journal-title":"JAHA"},{"key":"B71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cphy.c150016","article-title":"Glucose Transporters in Cardiac Metabolism and Hypertrophy","volume-title":"Comprehensive Physiology","author":"Shao","year":"2015"},{"key":"B72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cardiores.2007.05.004","article-title":"Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart","volume":"76","author":"Sharma","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1073\/pnas.92.23.10496","article-title":"Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood","volume":"92","author":"Strauss","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/medicina58010031","article-title":"Oxidative Stress Markers in Hypertrophic Cardiomyopathy","volume":"58","author":"Szygu\u0142a-Jurkiewicz","year":"2021","journal-title":"Medicina"},{"key":"B76","doi-asserted-by":"publisher","first-page":"670787","DOI":"10.3389\/fgene.2021.670787","article-title":"Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Genet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/biom9120878","article-title":"Hypertrophic Cardiomyopathy: An Overview of Genetics and Management","volume":"9","author":"Teekakirikul","year":"2019","journal-title":"Biomolecules"},{"key":"B78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bbadis.2014.02.001","article-title":"Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD\u2212\/\u2212) mice","volume":"1842","author":"Tucci","year":"2014","journal-title":"Biochimica Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/BF03164836","article-title":"Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: Assessment by F-18-FDG PET study","volume":"12","author":"Uehara","year":"1998","journal-title":"Ann. Nucl. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1161\/CIRCRESAHA.116.305420","article-title":"Maintaining Ancient Organelles: Mitochondrial Biogenesis and Maturation","volume":"116","author":"Vega","year":"2015","journal-title":"Circulation Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12968-016-0223-8","article-title":"Microvascular ischemia in hypertrophic cardiomyopathy: new insights from high-resolution combined quantification of perfusion and late gadolinium enhancement","volume":"18","author":"Villa","year":"2016","journal-title":"J. Cardiovasc. Magnetic Reson."},{"key":"B82","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.abb.2019.03.006","article-title":"Impaired calcium handling and mitochondrial metabolic dysfunction as early markers of hypertrophic cardiomyopathy","volume":"665","author":"Viola","year":"2019","journal-title":"Archives Biochem. Biophysics"},{"key":"B83","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/life10110277","article-title":"Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies","volume":"10","author":"Wasmus","year":"2020","journal-title":"Life"},{"key":"B84","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.freeradbiomed.2021.05.013","article-title":"Redox signaling in heart failure and therapeutic implications","volume":"171","author":"Weissman","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1089\/ars.2017.7236","article-title":"Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits","volume":"31","author":"Wijnker","year":"2019","journal-title":"Antioxidants and Redox Signal."},{"key":"B86","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.hlc.2019.12.005","article-title":"Hypertrophic Cardiomyopathy: Challenging the Status Quo?","volume":"29","author":"Younger","year":"2020","journal-title":"Heart, Lung Circulation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1509548","DOI":"10.3389\/fmicb.2025.1509548","article-title":"Cardiac energy metabolic disorder and gut microbiota imbalance: a study on the therapeutic potential of Shenfu Injection in rats with heart failure","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Microbiol."}],"updated-by":[{"DOI":"10.3389\/fphys.2025.1764781","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000}}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1700313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:40:04Z","timestamp":1767940804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1700313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":87,"alternative-id":["10.3389\/fphys.2025.1700313"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2025.1700313","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"article-number":"1700313"}}